Published in J Virol on September 06, 2006
Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol (2011) 2.26
Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. J Clin Invest (2013) 2.15
Rotaviruses: from pathogenesis to vaccination. Gastroenterology (2009) 2.05
The role of secretory antibodies in infection immunity. Nat Rev Microbiol (2010) 1.36
Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol (2013) 1.19
Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. J Virol (2008) 1.15
Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest (2010) 1.04
Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice. PLoS One (2013) 1.02
Development of a Bacillus subtilis-based rotavirus vaccine. Clin Vaccine Immunol (2010) 0.98
Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PLoS One (2013) 0.98
Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses. J Clin Invest (2013) 0.94
In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. PLoS One (2012) 0.89
Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial virus. PLoS One (2008) 0.84
Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles. Hum Vaccin Immunother (2013) 0.84
Why does the world need another rotavirus vaccine? Ther Clin Risk Manag (2008) 0.83
Immune mediators of rotavirus antigenemia clearance in mice. J Virol (2011) 0.83
Protection from Clostridium difficile infection in CD4 T Cell- and polymeric immunoglobulin receptor-deficient mice. Infect Immun (2013) 0.83
Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo. Hum Vaccin Immunother (2014) 0.83
The gastrointestinal frontier: IgA and viruses. Front Immunol (2013) 0.82
Matrix protein-specific IgA antibody inhibits measles virus replication by intracellular neutralization. J Virol (2011) 0.82
Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea. PLoS Pathog (2013) 0.82
Immunoglobulin A: A next generation of therapeutic antibodies? MAbs (2011) 0.81
Human plasma-derived polymeric IgA and IgM antibodies associate with secretory component to yield biologically active secretory-like antibodies. J Biol Chem (2012) 0.80
Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge. PLoS One (2014) 0.79
Heterosubtypic antiviral activity of hemagglutinin-specific antibodies induced by intranasal immunization with inactivated influenza viruses in mice. PLoS One (2013) 0.79
Antigenicity and immunogenicity of rotavirus VP6 protein expressed on the surface of Lactococcus lactis. Biomed Res Int (2013) 0.77
Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice. Microb Cell Fact (2015) 0.77
Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine. Hum Vaccin Immunother (2016) 0.76
Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease. PLoS One (2016) 0.75
Mutations in toll-like receptor 3 are associated with elevated levels of rotavirus-specific IgG antibodies in IgA-deficient but not IgA-sufficient individuals. Clin Vaccine Immunol (2013) 0.75
Homeostasis of the Gut Barrier and Potential Biomarkers. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus. Sci Rep (2016) 0.75
Enhanced differentiation of intraepithelial lymphocytes in the intestine of polymeric immunoglobulin receptor-deficient mice. Immunology (2015) 0.75
Functions of Antibodies. Microbiol Spectr (2014) 0.75
Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles. J Immunol Res (2016) 0.75
Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice. Front Plant Sci (2017) 0.75
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80
Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol (2004) 5.20
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science (1996) 3.07
Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity (2002) 2.17
Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J Virol (1985) 2.06
Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol (1995) 2.06
Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol (1994) 2.03
Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity (1998) 1.96
Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol (1995) 1.88
Rotavirus is released from the apical surface of cultured human intestinal cells through nonconventional vesicular transport that bypasses the Golgi apparatus. J Virol (1997) 1.87
Passive immunisation of children with bovine colostrum containing antibodies to human rotavirus. Lancet (1989) 1.84
Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J Gen Virol (1999) 1.73
Immunoglobulin transport across polarized epithelial cells. Nat Rev Mol Cell Biol (2002) 1.69
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol (1989) 1.58
Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology (1995) 1.56
Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med (1995) 1.54
Characterization of rotavirus cell entry. J Virol (2004) 1.46
Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis (1987) 1.44
Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J Virol (1998) 1.37
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest (2002) 1.34
CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G). J Virol (2002) 1.32
Rotavirus spike protein VP4 is present at the plasma membrane and is associated with microtubules in infected cells. J Virol (2000) 1.22
Genetics of the rotaviruses. Annu Rev Microbiol (1997) 1.18
Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18
Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J Virol (2002) 1.18
Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity (2003) 1.15
Protective intestinal anti-rotavirus B cell immunity is dependent on alpha 4 beta 7 integrin expression but does not require IgA antibody production. J Immunol (2001) 1.15
Antigen binding properties of purified immunoglobulin A and reconstituted secretory immunoglobulin A antibodies. J Biol Chem (1996) 1.14
Structure of rotavirus. Curr Top Microbiol Immunol (1994) 1.12
Microaerophilic conditions permit to mimic in vitro events occurring during in vivo Helicobacter pylori infection and to identify Rho/Ras-associated proteins in cellular signaling. J Biol Chem (2002) 1.08
Role of tyrosine phosphorylation in ligand-induced regulation of transcytosis of the polymeric Ig receptor. Mol Biol Cell (1998) 1.06
Intraepithelial cell neutralization of HIV-1 replication by IgA. J Immunol (2005) 1.05
Functional mapping of protective domains and epitopes in the rotavirus VP6 protein. J Virol (2000) 1.03
Dissecting rotavirus particle-raft interaction with small interfering RNAs: insights into rotavirus transit through the secretory pathway. J Virol (2006) 1.01
Production of human secretory component with dimeric IgA binding capacity using viral expression systems. J Biol Chem (1995) 1.01
Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation. J Virol (2002) 0.99
Topology of bovine rotavirus (RF strain) VP6 epitopes by real-time biospecific interaction analysis. Virology (1994) 0.97
Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea. J Virol (2000) 0.97
Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus. Virology (1996) 0.95
Secretory immunoglobulin A: from mucosal protection to vaccine development. Biol Chem (1999) 0.95
Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. J Virol (2006) 0.93
Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium. J Exp Med (1998) 0.92
Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA. Virology (2006) 0.89
Simplified procedure to recover recombinant antigenized secretory IgA to be used as a vaccine vector. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.87
WC3 reassortant vaccines in children. Arch Virol Suppl (1996) 0.85
Rotavirus assembly - interaction of surface protein VP7 with middle layer protein VP6. Arch Virol (2001) 0.80
Passive immunity against diarrhoea. Acta Paediatr (1996) 0.78
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med (2010) 3.20
Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology (2003) 2.61
A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro Oncol (2006) 2.49
Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut (2012) 2.32
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs (2005) 2.30
GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol (2006) 1.86
Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics (2009) 1.76
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76
Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunol Rev (2010) 1.70
Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis (2005) 1.52
Isotype modulates epitope specificity, affinity, and antiviral activities of anti-HIV-1 human broadly neutralizing 2F5 antibody. Proc Natl Acad Sci U S A (2012) 1.50
Existence of CD8α-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J Immunol (2010) 1.32
From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol (2010) 1.29
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs. Invest New Drugs (2004) 1.23
Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J Virol (2002) 1.18
Migratory monocytes and granulocytes are major lymphatic carriers of Salmonella from tissue to draining lymph node. J Leukoc Biol (2005) 1.15
Novel generations of influenza vaccines. Vaccine (2003) 1.14
Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci (2007) 1.13
Pharmacokinetic and tumor distribution characteristics of temsirolimus in patients with recurrent malignant glioma. Clin Cancer Res (2007) 1.13
Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs. Mol Ther (2007) 1.09
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol (2003) 1.08
Bluetongue virus targets conventional dendritic cells in skin lymph. J Virol (2009) 1.08
Principles, organization, and operation of a DNA bank for clinical trials: a Department of Veterans Affairs cooperative study. Control Clin Trials (2002) 1.08
Characterization of dendritic cells subpopulations in skin and afferent lymph in the swine model. PLoS One (2011) 1.07
Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine (2006) 1.05
Plasmacytoid dendritic cells migrate in afferent skin lymph. J Immunol (2008) 1.03
Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease. Inflamm Bowel Dis (2010) 1.02
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. J Neurooncol (2006) 1.02
β-arrestin-dependent activation of the cofilin pathway is required for the scavenging activity of the atypical chemokine receptor D6. Sci Signal (2013) 1.02
Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J Virol (2006) 0.99
Enrichment for a CD26hi SIRP- subset in lymph dendritic cells from the upper aero-digestive tract. J Leukoc Biol (2004) 0.99
Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France. Appl Health Econ Health Policy (2008) 0.98
Solution structure of human secretory component and implications for biological function. J Biol Chem (2007) 0.98
Rotavirus vaccines: considerations for successful implementation in Europe. Lancet Infect Dis (2006) 0.97
Quantitative evaluation of rotaviral antigenemia in children with acute rotaviral diarrhea. J Infect Dis (2006) 0.96
Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection. J Virol (2006) 0.93
Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Cancer (2004) 0.93
The double-stranded RNA bluetongue virus induces type I interferon in plasmacytoid dendritic cells via a MYD88-dependent TLR7/8-independent signaling pathway. J Virol (2012) 0.92
NS3 of bluetongue virus interferes with the induction of type I interferon. J Virol (2013) 0.90
The VP6 protein of rotavirus interacts with a large fraction of human naive B cells via surface immunoglobulins. J Virol (2004) 0.89
Sensing and control of bluetongue virus infection in epithelial cells via RIG-I and MDA5 helicases. J Virol (2012) 0.88
Effects of T cell-induced colonic inflammation on epithelial barrier function. Inflamm Bowel Dis (2010) 0.88
Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model. Graefes Arch Clin Exp Ophthalmol (2008) 0.87
Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine (2009) 0.87
Existence of conventional dendritic cells in Gallus gallus revealed by comparative gene expression profiling. J Immunol (2014) 0.85
A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus. Vaccine (2010) 0.84
Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn's disease. PLoS One (2013) 0.84
Issues and special features of animal health research. Vet Res (2011) 0.84
Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep. Vaccine (2010) 0.84
Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep. J Virol (2006) 0.83
Rearrangements of rotavirus genomic segment 11 are generated during acute infection of immunocompetent children and do not occur at random. J Virol (2008) 0.82
A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B. PLoS One (2009) 0.82
The immune status of bovine somatic clones. Cloning Stem Cells (2009) 0.80
No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye. Graefes Arch Clin Exp Ophthalmol (2010) 0.79
Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits. Transgenic Res (2005) 0.79
A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study. Neuro Oncol (2002) 0.78
Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery. Vaccine (2007) 0.78
Dendritic cell subtypes from lymph nodes and blood show contrasted gene expression programs upon Bluetongue virus infection. J Virol (2013) 0.78
Steady state pig dendritic cells migrating in skin draining pseudo-afferent lymph are semi-mature. Vet Immunol Immunopathol (2011) 0.77
Modified model of VX2 tumor overexpressing vascular endothelial growth factor. J Vasc Interv Radiol (2012) 0.77
IL6 and TNF expression in vessels and surrounding tissues after embolization with ibuprofen-loaded beads confirms diffusion of ibuprofen. Eur J Pharm Sci (2011) 0.76
Canine recombinant adenovirus vector induces an immunogenicity-related gene expression profile in skin-migrated CD11b⁺ -type DCs. PLoS One (2012) 0.76
Racecadotril in the Management of Rotavirus and Non-rotavirus Diarrhea in Under-five Children: Two Randomized, Double-blind, Placebo-controlled Trials. Indian Pediatr (2016) 0.76
Unsuspected glucose-6-phosphate dehydrogenase deficiency presenting as symptomatic methemoglobinemia with severe hemolysis after fava bean ingestion in a 6-year-old boy. Int J Hematol (2011) 0.76
Anti-inflammatory effect of ibuprofen-loaded embolization beads in sheep uterus. J Biomed Mater Res B Appl Biomater (2008) 0.75
Primary malignant brain tumor incidence and Medicaid enrollment. Neurology (2004) 0.75
Unraveling features of the natural MHC class II peptidome of skin-migrated dendritic cells. Int Immunol (2011) 0.75
Dietary polyunsaturated fatty acids reduce retinal stress induced by an elevation of intraocular pressure in rats. Nutr Res (2011) 0.75
Traumatic damage to the heart from cardiac massage. Surgery (1962) 0.75
Influence of degradation on inflammatory profile of polyphosphazene coated PMMA and trisacryl gelatin microspheres in a sheep uterine artery embolization model. Biomaterials (2011) 0.75
The European Paediatric Life Support course improves assessment and care of dehydrated children in the emergency department. Eur J Pediatr (2011) 0.75